Home » Analyst Articles – US

UBS Group Downgrades Vipshop (VIPS) to Sell

UBS Group lowered shares of Vipshop (NYSE:VIPS) from a neutral rating to a sell rating in a research report report published on Monday morning, BenzingaRatingsTable reports. VIPS has been the subject of a number of other reports. Zacks Investment Research downgraded Vipshop from a strong-buy rating to a hold rating in a research note on Saturday, January 19th. Bank of America downgraded Vipshop from a buy rating to a neutral rating and set a $6.92 target price for the company. in a research note on Tuesday, February 19th. Macquarie downgraded Vipshop... 
 

ValuEngine Downgrades Royal Gold (RGLD) to Hold

Royal Gold (NASDAQ:RGLD) (TSE:RGL) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Wednesday, ValuEngine reports. A number of other equities research analysts also recently issued reports on RGLD. BidaskClub downgraded shares of Royal Gold from a “buy” rating to a “hold” rating in a research note on Saturday, March 30th. BMO Capital Markets downgraded shares of Royal Gold from an “outperform” rating to a “market perform”... 
 

Copart (CPRT) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Copart (NASDAQ:CPRT) from a buy rating to a hold rating in a research note released on Tuesday, Zacks.com reports. According to Zacks, “Copart is expanding the network of facilities to manage inflating volumes, which will likely drive sales. Apart from expanding existing locations, it also engages in acquisitions to grow its market presence. Further, lower vehicle sales aided Copart to generate exceptional top-line performance. Over the past month, shares of Copart have outperformed the industry... 
 

Cadence Design Systems (CDNS) Price Target Raised to $73.00 at Royal Bank of Canada

Cadence Design Systems (NASDAQ:CDNS) had its target price raised by Royal Bank of Canada to $73.00 in a research report report published on Tuesday, The Fly reports. Royal Bank of Canada currently has an outperform rating on the software maker’s stock. A number of other brokerages have also recently issued reports on CDNS. Needham & Company LLC raised their target price on shares of Cadence Design Systems to $71.00 and gave the stock a positive rating in a report on Tuesday. KeyCorp began coverage on shares of Cadence Design Systems in... 
 

Snap (SNAP) Price Target Raised to $8.00 at UBS Group

Snap (NYSE:SNAP) had its target price lifted by investment analysts at UBS Group from $6.00 to $8.00 in a research note issued on Wednesday, BenzingaRatingsTable reports. The brokerage presently has a “sell” rating on the stock. UBS Group’s target price indicates a potential downside of 25.86% from the stock’s current price. A number of other research analysts also recently weighed in on the stock. Pivotal Research restated a “hold” rating and set a $6.00 price target on shares of Snap in a report on Wednesday,... 
 

La Jolla Pharmaceutical’s (LJPC) Buy Rating Reaffirmed at HC Wainwright

La Jolla Pharmaceutical (NASDAQ:LJPC)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report issued on Wednesday, AnalystRatings.com reports. They presently have a $26.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target would suggest a potential upside of 248.99% from the company’s previous close. The analysts wrote, “We base our $26 price target on a sum-of-the-parts analysis based on: (1) the P/E value of La Jolla’s current... 
 

ORIENTAL LD CO/ADR (OLCLY) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of ORIENTAL LD CO/ADR (OTCMKTS:OLCLY) from a hold rating to a sell rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Oriental Land Co., Ltd. operates and manages theme parks and hotels primarily in Japan. Oriental Land Co. is headquartered in Urayasu, Japan. “ Several other brokerages have also commented on OLCLY. ValuEngine lowered shares of ORIENTAL LD CO/ADR from a buy rating to a hold rating in a research note on Monday, February 4th. Jefferies Financial Group... 
 

Zynerba Pharmaceuticals (ZYNE) Earns “Buy” Rating from Canaccord Genuity

Canaccord Genuity reaffirmed their buy rating on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) in a report issued on Monday, 24/7 WallStreet reports. Canaccord Genuity currently has a $18.00 price objective on the stock. Several other analysts have also recently commented on the stock. ValuEngine cut shares of Zynerba Pharmaceuticals from a hold rating to a sell rating in a report on Tuesday, March 12th. Cantor Fitzgerald reiterated a buy rating and issued a $11.00 target price on shares of Zynerba Pharmaceuticals in a research note on Thursday,... 
 

Rogers Communications (RCI) Receives “Sector Perform” Rating from Scotia Howard Weill

Scotia Howard Weill restated their sector perform rating on shares of Rogers Communications (NYSE:RCI) (TSE:RCI.B) in a research report report published on Monday morning, FirstToMarketsRatingsTable reports. A number of other research analysts have also weighed in on the stock. Howard Weil lowered shares of Rogers Communications from a sector outperform rating to a sector perform rating in a research note on Monday. Scotiabank downgraded shares of Rogers Communications from a sector outperform rating to a sector perform rating in a report on Monday.... 
 

Thermo Fisher Scientific (TMO) Rating Reiterated by Needham & Company LLC

Needham & Company LLC reaffirmed their strong-buy rating on shares of Thermo Fisher Scientific (NYSE:TMO) in a research report released on Monday, Briefing.com Automated Import reports. They currently have a $312.00 price target on the medical research company’s stock, up from their prior price target of $271.00. A number of other equities analysts have also weighed in on the stock. Bank of America restated a buy rating and issued a $300.00 price objective (up from $285.00) on shares of Thermo Fisher Scientific in a report on Tuesday,... 
 

BidaskClub Lowers Benefitfocus (BNFT) to Sell

Benefitfocus (NASDAQ:BNFT) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, BidAskClub reports. Several other research analysts have also commented on the stock. Cantor Fitzgerald assumed coverage on shares of Benefitfocus in a report on Tuesday, April 2nd. They issued an “overweight” rating and a $60.00 price target on the stock. Zacks Investment Research lowered shares of Benefitfocus from a “buy”... 
 

Aurinia Pharmaceuticals (AUPH) Downgraded by BidaskClub

Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued to investors on Wednesday, BidAskClub reports. Several other brokerages also recently weighed in on AUPH. Zacks Investment Research raised shares of Aurinia Pharmaceuticals from a “hold” rating to a “buy” rating and set a $7.75 target price for the company in a report on Wednesday, January 9th. Raymond James upped their target price... 
 

Brookfield Infrastructure Partners (BIP) Upgraded by Zacks Investment Research to “Hold”

Brookfield Infrastructure Partners (NYSE:BIP) (TSE:BIP.UN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “BROOKFIELD INFRASTRUCTURE PARTNERS L.P. was established by Brookfield Asset Management as its primary vehicle to own and operate certain infrastructure assets on a global basis. Brookfield Infrastructure operates high quality, long-life assets that generate stable cash flows,... 
 

Zacks Investment Research Lowers CYBERAGENT INC/ADR (CYGIY) to Sell

Zacks Investment Research lowered shares of CYBERAGENT INC/ADR (OTCMKTS:CYGIY) from a hold rating to a sell rating in a report released on Tuesday morning, Zacks.com reports. According to Zacks, “CyberAgent Inc. provides internet services. Its business portfolio includes blog media website, internet ad business, game services and investment development business for smartphones and PC. CyberAgent Inc. is headquartered in Tokyo, Japan. “ Separately, ValuEngine lowered CYBERAGENT INC/ADR from a buy rating to a hold rating in a research... 
 

Twitter (TWTR) PT Raised to $40.00

Twitter (NYSE:TWTR) had its target price lifted by equities researchers at Wells Fargo & Co from $33.00 to $40.00 in a research note issued on Wednesday, The Fly reports. The firm currently has a “market perform” rating on the social networking company’s stock. Wells Fargo & Co‘s target price points to a potential upside of 3.95% from the company’s current price. Several other analysts also recently commented on the company. Vertical Group raised Twitter from a “hold” rating to a “buy”... 
 

Western Alliance Bancorporation (WAL) PT Raised to $58.00

Western Alliance Bancorporation (NYSE:WAL) had its price objective increased by equities research analysts at Wells Fargo & Co from $53.00 to $58.00 in a research note issued to investors on Wednesday, The Fly reports. The firm currently has an “outperform” rating on the financial services provider’s stock. Wells Fargo & Co‘s price target would suggest a potential upside of 22.88% from the company’s previous close. Several other research firms have also recently weighed in on WAL. Zacks Investment Research... 
 

J.Jill (JILL) Rating Increased to Sell at ValuEngine

J.Jill (NYSE:JILL) was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday, ValuEngine reports. A number of other analysts also recently issued reports on the stock. Wells Fargo & Co lowered their price target on shares of J.Jill from $7.00 to $6.00 and set a “market perform” rating on the stock in a report on Wednesday, January 2nd. TheStreet raised shares of J.Jill from a “d+” rating to a “c” rating in a report on... 
 

American National BankShares (AMNB) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of American National BankShares (NASDAQ:AMNB) from a sell rating to a hold rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “American National Bankshares Inc. is a one-bank holding company. “ Several other research firms also recently commented on AMNB. Raymond James set a $38.00 target price on American National BankShares and gave the stock a buy rating in a research report on Friday, January 18th. BidaskClub upgraded American National BankShares... 
 

Apple (AAPL) Price Target Raised to $234.00 at Morgan Stanley

Apple (NASDAQ:AAPL) had its price objective lifted by research analysts at Morgan Stanley from $220.00 to $234.00 in a report released on Wednesday, Marketbeat reports. The brokerage presently has an “overweight” rating on the iPhone maker’s stock. Morgan Stanley’s target price points to a potential upside of 13.99% from the stock’s previous close. A number of other analysts have also recently issued reports on the company. Goldman Sachs Group reiterated a “neutral” rating and set a $182.00 target price... 
 

Activision Blizzard (ATVI) Given “Overweight” Rating at Piper Jaffray Companies

Piper Jaffray Companies restated their overweight rating on shares of Activision Blizzard (NASDAQ:ATVI) in a research report sent to investors on Monday morning, The Fly reports. Other analysts also recently issued research reports about the stock. Wedbush reissued an outperform rating and set a $60.00 target price on shares of Activision Blizzard in a research report on Monday, April 1st. Robert W. Baird dropped their target price on shares of Activision Blizzard from $75.00 to $69.00 and set an outperform rating for the company in a research... 
 

Mateon Therapeutics’ (MATN) “Hold” Rating Reaffirmed at HC Wainwright

HC Wainwright restated their hold rating on shares of Mateon Therapeutics (OTCMKTS:MATN) in a report released on Monday morning, AnalystRatings.com reports. “Valuation and potential impediments to achieving it. We are maintaining our Neutral rating on the shares and continue to not issue a price target currently. As mentioned above, we would look to potentially reassess our valuation following closing of the merger, additional due diligence on the new entity, and visibility into the ability to fund its programs. Underlying risk in the shares... 
 

Enerplus (ERF) Upgraded to Strong-Buy by Zacks Investment Research

Enerplus (NYSE:ERF) (TSE:ERF) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Wednesday, Zacks.com reports. The firm presently has a $11.00 target price on the oil and natural gas company’s stock. Zacks Investment Research‘s price target points to a potential upside of 17.65% from the company’s current price. According to Zacks, “Enerplus Corporation, formerly known as Enerplus Resources, is an independent oil and gas production... 
 

Genmab A/S (GNMSF) Upgraded at Zacks Investment Research

Genmab A/S (OTCMKTS:GNMSF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The firm presently has a $187.00 target price on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 13.92% from the stock’s previous close. According to Zacks, “Genmab A/S is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases.... 
 

Franklin Electric (FELE) Downgraded by ValuEngine

Franklin Electric (NASDAQ:FELE) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Wednesday, ValuEngine reports. A number of other equities research analysts have also commented on FELE. Zacks Investment Research lowered Franklin Electric from a “hold” rating to a “sell” rating in a research report on Monday, January 28th. Boenning Scattergood reiterated a “buy” rating and set a $54.00 price target on shares of Franklin... 
 

Gilead Sciences (GILD) Given a $85.00 Price Target at Oppenheimer

Oppenheimer set a $85.00 price objective on Gilead Sciences (NASDAQ:GILD) in a research report released on Monday morning, TipRanks reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other research firms have also issued reports on GILD. Wells Fargo & Co reduced their target price on Gilead Sciences from $95.00 to $89.00 and set an outperform rating for the company in a report on Tuesday, February 5th. Citigroup restated a buy rating and issued a $100.00 target price on shares of Gilead... 
 

Eurofins Scientific (ERFSF) Upgraded to Hold by Zacks Investment Research

Eurofins Scientific (OTCMKTS:ERFSF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates... 
 

BidaskClub Upgrades Omega Flex (OFLX) to Strong-Buy

Omega Flex (NASDAQ:OFLX) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Thursday, BidAskClub reports. Shares of OFLX traded down $5.33 during trading hours on Thursday, hitting $89.42. The company had a trading volume of 8,868 shares, compared to its average volume of 6,892. The company has a market cap of $902.25 million, a P/E ratio of 46.47 and a beta of 1.08. Omega Flex has a 52-week low of $51.02 and a 52-week high of $96.00. Omega Flex (NASDAQ:OFLX)... 
 

AcelRx Pharmaceuticals (ACRX) Stock Rating Upgraded by BidaskClub

AcelRx Pharmaceuticals (NASDAQ:ACRX) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, BidAskClub reports. Several other analysts have also recently issued reports on ACRX. Zacks Investment Research cut shares of AcelRx Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Thursday, January 3rd. Cantor Fitzgerald set a $9.00 price target on shares of AcelRx Pharmaceuticals and gave the... 
 

Global Blood Therapeutics (GBT) Stock Rating Lowered by BidaskClub

Global Blood Therapeutics (NASDAQ:GBT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, BidAskClub reports. Other research analysts have also issued research reports about the company. Wedbush reissued an “outperform” rating and issued a $95.00 target price on shares of Global Blood Therapeutics in a research report on Thursday, April 18th. William Blair reissued a “buy” rating on shares of Global Blood Therapeutics... 
 

Zacks Investment Research Lowers Crescent Point Energy (CPG) to Hold

Crescent Point Energy (NYSE:CPG) (TSE:CPG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Crescent Point Energy Corp. is engaged in the acquisition, exploration and development of oil and natural gas properties in Western Canada. The Company’s operations consist of light and medium oil and natural gas assets strategically focused in core areas in southern Saskatchewan and central and southern... 
 

Altus Midstream (ALTM) Raised to Hold at Zacks Investment Research

Altus Midstream (NYSE:ALTM) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Altus Midstream Company is a pure-play, Permian Basin midstream C-corporation. The company or its subsidiaries own substantially all of the gas gathering, processing and transportation assets servicing Apache Corporation’s production in the Alpine High play in the Delaware Basin. Altus Midstream Company, formerly known as Kayne... 
 

Tocagen (TOCA) Now Covered by Analysts at Cantor Fitzgerald

Equities research analysts at Cantor Fitzgerald assumed coverage on shares of Tocagen (NASDAQ:TOCA) in a research report issued to clients and investors on Thursday, The Fly reports. The brokerage set an “overweight” rating on the stock. Several other research firms have also commented on TOCA. Zacks Investment Research lowered shares of Tocagen from a “buy” rating to a “hold” rating in a research report on Saturday, January 26th. B. Riley initiated coverage on shares of Tocagen in a report on Monday, December... 
 

Twilio (TWLO) Raised to “Buy” at Zacks Investment Research

Twilio (NYSE:TWLO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The brokerage currently has a $143.00 price objective on the technology company’s stock. Zacks Investment Research‘s price objective suggests a potential upside of 8.30% from the company’s previous close. According to Zacks, “Twilio is benefiting from a solid product menu and an increasing customer base. The company... 
 

Tesla (TSLA) PT Lowered to $369.00

Tesla (NASDAQ:TSLA) had its price target cut by analysts at JMP Securities from $374.00 to $369.00 in a research note issued to investors on Thursday, BenzingaRatingsTable reports. The brokerage presently has a “market outperform” rating on the electric vehicle producer’s stock. JMP Securities’ price target suggests a potential upside of 48.63% from the company’s previous close. Other analysts also recently issued research reports about the company. ValuEngine downgraded Tesla from a “strong-buy” rating... 
 

Zacks Investment Research Downgrades Targa Resources (TRGP) to Strong Sell

Targa Resources (NYSE:TRGP) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued on Thursday, Zacks.com reports. According to Zacks, “Targa Resources Corp owns general and limited partner interests in Targa Resources Partners LP, engaged in providing midstream natural gas and natural gas liquid services in the United States. The Company operates its business through two business segments: Natural Gas Gathering and Processing and NGL Logistics and Marketing.... 
 

CNX Resources (CNX) Downgraded by Zacks Investment Research to “Hold”

CNX Resources (NYSE:CNX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “CNX Resources' focus on low-cost production areas and increasing consciousness to lower emissions will drive demand for natural gas and are going to act as tailwinds. Share buyback, selling off its non-core assets and increasing focus on Marcellus and Utica shales are also going to strengthen the company’s... 
 

Surgery Partners (SGRY) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Surgery Partners (NASDAQ:SGRY) from a strong sell rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “Surgery Partners, Inc. is a healthcare services company. The Company’s outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery... 
 

Aclaris Therapeutics (ACRS) Upgraded at BidaskClub

BidaskClub upgraded shares of Aclaris Therapeutics (NASDAQ:ACRS) from a strong sell rating to a sell rating in a research note issued to investors on Wednesday morning, BidAskClub reports. Several other equities research analysts have also commented on the stock. Cantor Fitzgerald restated a buy rating and set a $50.00 target price on shares of Aclaris Therapeutics in a research report on Friday, March 15th. ValuEngine lowered shares of Aclaris Therapeutics from a hold rating to a sell rating in a research report on Wednesday, January 2nd. Finally,... 
 

ANNALY CAP MGMT/SH (NLY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of ANNALY CAP MGMT/SH (NYSE:NLY) from a hold rating to a strong-buy rating in a research note issued to investors on Wednesday, Zacks.com reports. Zacks Investment Research currently has $12.00 target price on the real estate investment trust’s stock. According to Zacks, “Shares of Annaly have outperformed its industry over the past six months. Further, the trend in estimate revisions for 2019 earnings per share indicates a favorable outlook for the company. Notably, Annaly’s prudent selection... 
 

GENFIT S A/ADR (GNFT) Research Coverage Started at Leerink Swann

Leerink Swann initiated coverage on shares of GENFIT S A/ADR (NASDAQ:GNFT) in a research report released on Wednesday morning, The Fly reports. The brokerage issued an outperform rating and a $25.47 target price on the stock. A number of other research analysts have also weighed in on GNFT. Barclays initiated coverage on shares of GENFIT S A/ADR in a research note on Monday. They issued an overweight rating and a $55.00 price objective on the stock. HC Wainwright dropped their price objective on shares of GENFIT S A/ADR to $72.00 and set a buy rating... 
 

Zacks Investment Research Upgrades Summit Midstream Partners (SMLP) to “Buy”

Summit Midstream Partners (NYSE:SMLP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday, Zacks.com reports. The firm presently has a $10.00 price objective on the pipeline company’s stock. Zacks Investment Research‘s price objective suggests a potential upside of 11.36% from the company’s previous close. According to Zacks, “Summit Midstream Partners, LP is focused on owning and operating midstream energy infrastructure that are located... 
 

Energizer (ENR) Stock Rating Upgraded by TheStreet

TheStreet upgraded shares of Energizer (NYSE:ENR) from a c+ rating to a b- rating in a research report released on Tuesday, TheStreetRatingsTable reports. A number of other equities analysts have also weighed in on the stock. Zacks Investment Research upgraded shares of Energizer from a sell rating to a hold rating in a research report on Tuesday, April 16th. Goldman Sachs Group upgraded shares of Energizer from a neutral rating to a buy rating and lifted their price objective for the company from $48.00 to $60.00 in a research report on Sunday,... 
 

Proofpoint (PFPT) PT Raised to $125.00

Proofpoint (NASDAQ:PFPT) had its price target lifted by equities research analysts at Deutsche Bank from $95.00 to $125.00 in a research report issued on Thursday, BenzingaRatingsTable reports. The firm presently has a “hold” rating on the software maker’s stock. Deutsche Bank’s target price indicates a potential downside of 2.57% from the stock’s previous close. A number of other research firms also recently issued reports on PFPT. Monness Crespi & Hardt lifted their price objective on shares of Proofpoint from... 
 

Dave & Buster’s Entertainment (PLAY) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of Dave & Buster’s Entertainment (NASDAQ:PLAY) from a sell rating to a hold rating in a research report sent to investors on Wednesday, BidAskClub reports. PLAY has been the topic of several other research reports. BMO Capital Markets reiterated an outperform rating and set a $66.00 target price (up previously from $62.00) on shares of Dave & Buster’s Entertainment in a report on Wednesday, April 3rd. Zacks Investment Research lowered Dave & Buster’s Entertainment from a hold rating to a... 
 

Sherwin-Williams (SHW) Given New $470.00 Price Target at Barclays

Sherwin-Williams (NYSE:SHW) had its price target raised by Barclays from $440.00 to $470.00 in a research note released on Wednesday, BenzingaRatingsTable reports. They currently have an equal weight rating on the specialty chemicals company’s stock. Several other brokerages have also issued reports on SHW. KeyCorp decreased their price target on shares of Sherwin-Williams from $500.00 to $450.00 and set an overweight rating on the stock in a report on Wednesday, January 16th. Zacks Investment Research lowered shares of Sherwin-Williams from... 
 

Mizuho Reaffirms Buy Rating for Revance Therapeutics (RVNC)

Mizuho reaffirmed their buy rating on shares of Revance Therapeutics (NASDAQ:RVNC) in a research report report published on Wednesday morning, AnalystRatings.com reports. The brokerage currently has a $37.00 price target on the biopharmaceutical company’s stock. “We estimate a floor valuation of $17/share which includes: additional dilutive financing, Fosun deal, no credit for therapeutics, poor performance in U.S. aesthetics. With credit for therapeutics and fair aesthetic assumptions, we see ~180%+ upside to our base case $37 PT.”,”... 
 

Tesla (TSLA) Given a $325.00 Price Target at Sanford C. Bernstein

Tesla (NASDAQ:TSLA) has been assigned a $325.00 price target by equities research analysts at Sanford C. Bernstein in a report released on Thursday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the electric vehicle producer’s stock. Sanford C. Bernstein’s target price indicates a potential upside of 28.73% from the company’s current price. A number of other equities research analysts also recently issued reports on the stock. JMP Securities set a $408.00 price target on shares of Tesla... 
 

Attunity (ATTU) Stock Rating Upgraded by Zacks Investment Research

Zacks Investment Research upgraded shares of Attunity (NASDAQ:ATTU) from a hold rating to a buy rating in a research report released on Wednesday morning, Zacks.com reports. They currently have $26.00 price objective on the technology company’s stock. According to Zacks, “Attunity is the leading provider of service-orientated software and solutions in the Workplace Applications market. Using Attunity’s software, companies can seamlessly and efficiently connect, transfer, join and stream to and from virtually any data source in... 
 

Lockheed Martin (LMT) Upgraded to “Buy” at Zacks Investment Research

Lockheed Martin (NYSE:LMT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday, Zacks.com reports. The firm currently has a $373.00 target price on the aerospace company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 12.55% from the company’s previous close. According to Zacks, “Lockheed Martin ended the first quarter of 2019 on an impressive note, wherein earnings and revenues surpassed the... 
 

CIT Group (CIT) Given New $60.00 Price Target at UBS Group

CIT Group (NYSE:CIT) had its price objective hoisted by UBS Group from $55.00 to $60.00 in a report published on Wednesday morning, BenzingaRatingsTable reports. They currently have a buy rating on the financial services provider’s stock. Other research analysts have also issued reports about the stock. TheStreet raised shares of CIT Group from a c+ rating to a b rating in a research note on Monday, March 25th. Zacks Investment Research raised shares of CIT Group from a hold rating to a buy rating and set a $48.00 target price for the company... 
 
© 2006-2019 Ticker Report